Latest Medtech News
Updated: 19 October 2026
Stryker is one of the largest medical device companies in the world, and one of the most acquisitive: more than 60 acquisitions under outgoing CEO Kevin Lobo, spanning orthopaedics, surgical robotics, neurotechnology and, more recently, peripheral vascular. In October 2026 it named a new CEO and placed a $400M bet on soft-tissue robotics, so 2027 looks like a new chapter.
We update this tracker monthly with Stryker's most relevant activity: acquisitions, product launches, regulatory milestones and leadership moves. Plus a look back at the deals that shaped the company.
As an executive search partner to the MedTech industry, Guided Solutions keeps a close eye on stories like these. Subscribe to our Industry Insights for weekly coverage.
Stryker at a Glance
| Headquarters | Portage, Michigan, USA |
| Listed | NYSE: SYK |
| CEO | Kevin Lobo (Spencer Stiles from 1 January 2027) |
| Annual net sales | More than $26B in 2026 |
| Latest quarter | Q2 2026: $6.6B net sales, up 9.4% |
| Segments | MedSurg & Neurotechnology ($3.6B in Q2 2026); Orthopaedics ($3.0B in Q2 2026) |
| Biggest recent deal | Inari Medical, $4.9B (2025) |
| Next results | Q3 2026, 29 October 2026 |
Stryker in 2026: What's Happened So Far
Stryker Launches Sonopet 3 Ultrasonic Aspirator (October 2026) The third generation of Stryker's ultrasonic tissue removal system, pitched on greater power and precision, extends its neurotechnology franchise.
Stryker Invests ~$400M in CMR Surgical, With an Option to Buy (October 2026) Stryker is taking a roughly $400M (£300M) preferred equity stake in UK-based CMR Surgical, with an exclusive option to acquire 100% of the company. Stryker also becomes the exclusive U.S. sales agent for the Versius surgical robot. It is Stryker's first major move into soft-tissue robotics, an area Mako never covered.
Spencer Stiles Named Stryker's Next CEO (October 2026) President and COO Spencer Stiles will succeed Kevin Lobo as CEO on 1 January 2027, with Lobo becoming Executive Chair. Stiles joined Stryker's Endoscopy business in 1999 and later ran Orthopaedics and the company's M&A strategy, including the Wright Medical deal and the spine separation. Under Lobo, annual sales tripled from $8.7B in 2012 to more than $26B.
Stryker Showcases Foot & Ankle Innovation at AOFAS 2026 (September 2026) Stryker presented Prophecy Surgical Planning for its Incompass total ankle system and the Hoffmann LRF smartHEX external fixation system.
Stryker to Acquire ZuriMED (August 2026) Stryker signed a definitive agreement to acquire ZuriMED, adding the FiberLocker system for rotator cuff repair to its shoulder portfolio.
Stryker Reports Q2 2026 Results: $6.6B in Sales, Up 9.4% (July 2026) Organic sales grew 9.0%, with MedSurg & Neurotechnology at $3.6B and Orthopaedics at $3.0B. Stryker narrowed its full-year organic growth guidance to 8.3% to 9.3%, and said it had made significant progress recovering from its cyber incident.
Stryker Completes Acquisition of Amplitude Vascular Systems (May 2026) Boston-based AVS develops a CO2-powered intravascular lithotripsy (IVL) platform for heavily calcified peripheral artery disease. It is the next step in the peripheral vascular platform Stryker started building with Inari, and puts it up against J&J's Shockwave in IVL.
Spencer Stiles Becomes President and COO (January 2026) Stiles moved up from Group President, Orthopaedics, nine months before being named CEO-elect.
Stryker Deal History
Stryker Sells Its Spinal Implants Business to VB Spine (2025) Stryker sold its U.S. spinal implants business to the Viscogliosi Brothers, creating VB Spine, which keeps exclusive access to Mako Spine and Copilot. Stryker stays in spine through interventional spine and enabling technologies. VB Spine has since acquired Augmedics' navigation technology.
Stryker Completes $4.9B Acquisition of Inari Medical (February 2025) Announced days into 2025 and closed less than a month later, Inari gave Stryker a venous thromboembolism business and the base of its peripheral vascular platform. The Artix Thrombectomy System followed.
Stryker Acquires Vertos Medical (2024) Added the minimally invasive mild procedure for lumbar spinal stenosis to Stryker's interventional spine business.
Stryker Adds care.ai, NICO and Molli Surgical (2024) Three tuck-ins in one year: smart hospital software, brain surgery devices and breast surgery markers.
Stryker Acquires Vocera Communications (~$3B, 2022) Added clinical communication and workflow technology for hospitals.
Stryker Completes Wright Medical Acquisition (November 2020) One of Stryker's largest deals, about $4B ($5.4B including debt), strengthening trauma and extremities. To satisfy antitrust regulators, Stryker sold its total ankle and finger joint implant assets to DJO.
Stryker Launches ProCuity, the First Fully Wireless Hospital Bed (October 2020) ProCuity connects to nurse call systems without cables and launched in more than 70 countries.
This page is updated on a monthly basis to reflect Stryker's ongoing activity.
Visit our Boston Scientific news tracker
Visit our Medtronic news tracker
